German biomaterials developer AMSilk has secured €52m in fresh financing to accelerate the commercial roll-out of its silk-protein materials. The funding is a vote of confidence for bio-based fibres at a time when funding has tightened across the materials innovation space. The round was led by existing backer ATHOS (AT Newtec) with participation from fellow incumbents MIG Capital and Novo Holdings.
This is Premium Content
Only user with Online and Print subscription can access this.
If you are a Free Subscriber, click here to upgrade.
If you already have Online or Print subscription Login To Unlock The Content!
